ArticleCroatian medical journal2017

Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients.

Vlatko Pejša et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.